| Cell line name |
EV-SCC-18 |
|---|
| Synonyms |
EVSCC 18; EVSCC18; Eastern Virginia-Squamous Cell Carcinoma-18 |
|---|
| Accession |
CVCL_RK09 |
|---|
| Resource Identification Initiative |
To cite this cell line use: EV-SCC-18 (RRID:CVCL_RK09) |
|---|
| Disease |
Laryngeal squamous cell carcinoma (NCIt: C4044)
Squamous cell carcinoma of the larynx (ORDO: Orphanet_494550) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
67Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=8552396
Ankita M. Patel, Leonard S. Incognito, Gary L. Schechter, William J. Wasilenko, Kenneth D. Somers;
Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
Oncogene 12:31-35(1996) PubMed=9815580
Yang-Guan Wu, Ann J. Palad, William J. Wasilenko, Peter F. Blackmore, William A. Pincus, Gary L. Schechter, Joseph R. Spoonster, Elise C. Kohn, Kenneth D. Somers;
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
Clin. Cancer Res. 3:1915-1921(1997) PubMed=17312569; DOI=10.1002/hed.20478
Charles J. Lin, Jennifer Rubin Grandis, Thomas E. Carey, Susanne M. Gollin, Theresa L. Whiteside, Wayne M. Koch, Robert Louis Ferris, Stephen Y. Lai;
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.
Head Neck 29:163-188(2007) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54832954
|
|---|
| Entry history |
|---|
| Entry creation | 05-Mar-2018 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 4 |
|---|
